Aperio Group, LLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 300 filers reported holding HAEMONETICS CORP in Q4 2019. The put-call ratio across all filers is 0.11 and the average weighting 0.1%.

Quarter-by-quarter ownership
Aperio Group, LLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q4 2020$1,406,000
+64.8%
11,845
+21.2%
0.00%
+33.3%
Q3 2020$853,000
-15.3%
9,776
-13.1%
0.00%
-25.0%
Q2 2020$1,007,000
-21.1%
11,246
-12.2%
0.00%
-33.3%
Q1 2020$1,277,000
-5.9%
12,815
+8.5%
0.01%
+20.0%
Q4 2019$1,357,000
-19.5%
11,813
-11.6%
0.01%
-28.6%
Q3 2019$1,686,000
+19.2%
13,365
+13.6%
0.01%
+16.7%
Q2 2019$1,415,000
-5.9%
11,761
-31.5%
0.01%0.0%
Q1 2019$1,503,000
-28.9%
17,181
-18.6%
0.01%
-45.5%
Q4 2018$2,113,000
+5.7%
21,116
+21.0%
0.01%
+22.2%
Q3 2018$1,999,000
+87.9%
17,446
+47.0%
0.01%
+80.0%
Q2 2018$1,064,000
+25.3%
11,867
+2.3%
0.01%
+25.0%
Q1 2018$849,000
+28.4%
11,598
+1.9%
0.00%
+33.3%
Q4 2017$661,000
+38.0%
11,385
+6.7%
0.00%0.0%
Q3 2017$479,000
+13.5%
10,670
-0.2%
0.00%0.0%
Q2 2017$422,000
+11.9%
10,695
+15.0%
0.00%0.0%
Q1 2017$377,000
+0.5%
9,302
-0.2%
0.00%0.0%
Q4 2016$375,000
+42.0%
9,318
+27.6%
0.00%
+50.0%
Q3 2016$264,000
-8.7%
7,303
-11.7%
0.00%0.0%
Q1 2016$289,000
+4.7%
8,275
-3.2%
0.00%
-33.3%
Q4 2015$276,000
-31.3%
8,551
-31.3%
0.00%
-25.0%
Q3 2015$402,000
-34.7%
12,451
-16.4%
0.00%
-33.3%
Q2 2015$616,000
-5.4%
14,898
+2.9%
0.01%
-14.3%
Q1 2015$651,000
+31.5%
14,484
+9.4%
0.01%
+16.7%
Q4 2014$495,000
+46.9%
13,240
+37.2%
0.01%
+20.0%
Q3 2014$337,000
-1.5%
9,648
-0.4%
0.01%0.0%
Q2 2014$342,0009,6870.01%
Other shareholders
HAEMONETICS CORP shareholders Q4 2019
NameSharesValueWeighting ↓
Iron Triangle Partners LP 330,000$36,633,0004.66%
BEACONLIGHT CAPITAL, LLC 156,395$17,361,0002.80%
Bridge City Capital, LLC 48,011$5,330,0001.77%
Summit Creek Advisors LLC 121,362$13,472,0001.61%
Sivik Global Healthcare LLC 25,000$2,775,0001.01%
ANCHOR CAPITAL ADVISORS LLC 412,218$45,760,0000.97%
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income 69,655$7,732,0000.90%
Orbimed Advisors 852,000$94,581,0000.88%
LONDON CO OF VIRGINIA 1,057,738$117,420,0000.67%
WEXFORD CAPITAL LP 40,138$4,456,0000.66%
View complete list of HAEMONETICS CORP shareholders